Slide Presentation from the AHRQ 2007 Annual Conference

AHRQ HS 10403-07: CQI in Medicine

The slide presents two charts.

The first chart has two panels. Panel 1 shows use of ß-blocade (n = 107 sites) versus control (n = 101 sites), from Spring 2000 through Spring 2002. During the period studied, the use of ß-blocade increased from just over 60% to about 68%. The control increased from under 58% to almost 66%.

Panel 2 shows use of IMA grafting (n = 101 sites) versus control (n = 101 sites), from Spring 2000 through Spring 2002. During the period studied, the use of IMA grafting increased from around 74% to around 86%. The control increased from 73% to 84%.

A note reads: "In both panels, the first intervention round began in January 2001. In both groups, the intervention resulted in an increase in measure use: this difference vs. contol in this preintervention/postintervention analysis was significant for the ß-blocade group (P = .04)."

Source: Ferguson, TB Jr. JAMA 2004.

The second chart on the slide shows sustainability. A scatterchart shows the percentage of patients receiving betablockers (BB) and a control group. Lines show the trends for both. Both lines rise with a similar curve, but the trend line for the betablock group rises higher than the control. They both begin at 60% at the beginning of the study. The BB trend line is at about 76% after 60 months and the control is at about 70% after 60 months.

Text below charts reads: "Used clinical data systems to establish the infrastructure for continuous quality improvement with process and outcomes data."